Uncovering Pathways to Personalized Therapies in Type 1 Diabetes.

Uncovering Pathways to Personalized Therapies in Type 1 Diabetes.
复制标题

DOI:
10.2337/db20-1185
复制
发表时间:
2021-04
期刊:
影响因子:
7.7
通讯作者:
Nepom GT
Nepom GT
中科院分区:
医学1区
文献类型:
--
作者:
Linsley PS;Greenbaum CJ;Nepom GT

文献摘要

参考文献

被引文献

相似文献

The goal of personalized medicine is to match the right drugs to the right patients at the right time. Personalized medicine has been most successful in cases where there is a clear genetic linkage between a disease and a therapy. This is not the case with type 1 diabetes (T1D), a genetically complex immune-mediated disease of β-cell destruction. Researchers over decades have traced the natural history of disease sufficiently to use autoantibodies as predictive biomarkers for disease risk and to conduct successful clinical trials of disease-modifying therapy. Recent studies, however, have highlighted heterogeneity associated with progression, with nonuniform rate of insulin loss and distinct features of the peri-diagnostic period. Likewise, there is heterogeneity in immune profiles and outcomes in response to therapy. Unexpectedly, from these studies demonstrating perplexing complexity in progression and response to therapy, new biomarker-based principles are emerging for how to achieve personalized therapies for T1D. These include therapy timed to periods of disease activity, use of patient stratification biomarkers to align therapeutic target with disease endotype, pharmacodynamic biomarkers to achieve personalized dosing and appropriate combination therapies, and efficacy biomarkers for “treat-to-target” strategies. These principles provide a template for application of personalized medicine to complex diseases.
DOI: 10.1007/s00125-016-3917-4
发表时间: 2016-06
期刊: Diabetologia
影响因子: 8.2
作者:
Gitelman SE;Gottlieb PA;Felner EI;Willi SM;Fisher LK;Moran A;Gottschalk M;Moore WV;Pinckney A;Keyes-Elstein L;Harris KM;Kanaparthi S;Phippard D;Ding L;Bluestone JA;Ehlers MR;ITN START Study Team
通讯作者: ITN START Study Team
DOI: 10.1172/jci.insight.120877
发表时间: 2018-08-09
期刊: JCI INSIGHT
影响因子: 8
作者:
Evans-Molina, Carmella;Sims, Emily K.;Sosenko, Jay M.
通讯作者: Sosenko, Jay M.
DOI: 10.2337/db19-0119
发表时间: 2019-07-01
期刊: DIABETES
影响因子: 7.7
作者:
Ahmed, Simi;Cerosaletti, Karen;Brusko, Todd M.
通讯作者: Brusko, Todd M.
DOI: 10.1056/nejmoa1902226
发表时间: 2019-08-15
影响因子: 158.5
作者:
Herold, Kevan C.;Bundy, Brian N.;Greenbaum, Carla J.
通讯作者: Greenbaum, Carla J.
DOI: 10.1210/jc.2016-2773
发表时间: 2017-07-01
影响因子: 5.8
作者:
Courtade, Jaques A.;Klimek-Abercrombie, Agnieszka M.;Verchere, C. Bruce
通讯作者: Verchere, C. Bruce